Crizotinib
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Descriptive Observational Study ALK-2016-CPHG (NCT03718117) | Pfizer | 2017-01-03 |
| Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC (NCT01945021) | Pfizer | 2013-09-30 |
Track Crizotinib automatically
Every clearance here is in the API, with alerts when new ones post.